40th pharmacovigilance UK & EU 2026 is organized by Virtue Insight and will be held from Mar 11 - 12, 2026 at Sheraton Skyline Hotel London Heathrow, London, England, United Kingdom.
Description:
This event will bring together top pharmaceutical, biotechnology and regulatory representatives under one roof that will address the key issues of the industry. Take a chance and make it count by attending our event to network with your peers, exchange expertise and experiences, and arm yourself with the latest information to take your department to the next level. It gives me great pleasure in welcoming all of you to the Virtue Insight’s 40th Pharmacovigilance UK & EU 2026. I wish and pray that all our efforts will be beneficial to our industries and to our all at large.
Key Themes Discussed This Year:
Key Speakers:
KARSTEN LOLLIKE, Scientific VP, Deputy QPPV, Global Patient Safety, Novo Nordisk
STEPHANIE MILLICAN, Deputy Director BRE II, MHRA
MICHAEL BEAN, Senior Director, Regulatory Compliance, Johnson & Johnson
JEAN-MARC HAUSLER, Global Head of International Patient Safety, F. Hoffmann-La Roche
CHETAN SHATAPATHY, Executive Director & Head, ADC Group, Patient Safety Oncology, AstraZeneca
LEONA HOUGHTON, Vice President, Global Safety (Ex-US), Mundipharma
MIRCEA CIUCA, Independent PV Consultant / International PV Expert (Former Global Head Medical Safety, Organon)
MIJAL CHAVDA, Senior Director, Global Head of GxP Inspections & GVP Quality, Kyowa Kirin
REMCO M. DIAB, Sr. Dir. Lead Global Safety Officer Immunology & Inflammation, Sanofi
VALENTINA MANCINI, Senior Director Pharmacovigilance, QPPV, Shionogi Europe
JUDY BARRETTO, Senior Director, Virology TA, Patient Safety, Gilead Sciences
CHRISTIAN MUHL, Senior Director Compliance, GSK
MARIJA SIMIC, Director Medical Safety Team Lead, Global Patient Safety, Sandoz
PAV RISHIRAJ, Director, Head of Pharmacovigilance, Ipsen
CALVIN JOHNSON, Executive Director & Head of International Patient Safety, Bristol-Myers Squibb
JASON BRYANT, SVP, Product Management, AI, ArisGlobal
LEA GALOVIC, Associate Director¸ Risk Management, Global Patient Safety & PV, Teva
YVONNE NANCIU, Country Head Pharmacovigilance Deputy EU QPPV, Bayer
PUNAM KUMARI, Founder & MD, Biovance Solutions
TEA BABIC, Director, PV Audits & Inspections, Teva
TERESA SARAGOCA, Director, Regulatory Affairs & Technical Manager, ITALFARMACO
SMRUTTI KOTHARI, Associate Director, Global Patient Safety. Quality & Compliance, Regeneron Pharmaceuticals
SABINE POLTERMANN, Head of Country Patient Safety Switzerland, Bristol-Myers Squibb
JOHN SOLOMON, Former Head of Pharmacovigilance - UK & Ireland, Sanofi
BEGUM BENLI PEKER, Head of Patient Safety EU Hub, Bristol-Myers Squibb
SIMON ASHWORTH, Head of Pharmacovigilance & Medical Safety, MENARINI Group
SUMIT MUNJAL, Global Head of Medical Safety, Otsuka Pharmaceuticals
RISHI CHOPRA, Head of International PV & Global PV Operations | Dep. UK QPPV, CSL Behring
PHILLIP EICHORN, Global Head of Drug Safety, Amryt Pharma
GALINA CORDERO, Head of Pharmacovigilance Dept, QPPV, JSC Farmak
WOLF HENNING GEBHARDT, R&D Scientist Advanced Analytics, Abbott
ABIDALI FAZAL, Safety Science Director, Roche
MARJAN DZEPAROSKI, Head of Regulatory Affairs, Drug Safety & Intelectual Property, Bionika Pharmaceuticals
RUDI SCHEERLINCK, Safety Strategy Lead – Oncology, Healthcare Business of Merck
MICHAEL VON FORSTNER, Chief Scientific Officer, MedGenie
RAGHDA MOHAMED, Patient Safety Cluster Lead - Middle East & Turkey / Global patient Safety Evaluation, Takeda Pharmaceuticals
LEONARDO PEREIRA, Clinical Safety Director, Roche
REEM YASIN, Quality Assurance & PV Manager, Hawkary Pharmaceuticals
ARUN RAVINDRAN, Benefit Risk Lead (Late phase Clinical, Development Safety), UCB
ZINA SADEQ, Director, Regional PV & Alliance Management, UK QPPV, Amicus Therapeutics
CINTHYA GALICIA QUINTANAR, Senior Manager, Country Safety Lead, Pfizer
SANJEEV SRIVASTAV, Signal Management Lead, BioNTech
Copyrights © 2026 eMedEvents Corporation, All Rights Reserved